文献速递免疫规划卫生政策与健康促进

荷兰水痘与其他疫苗可预防疾病的疾病负担比较

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.
PubMed 文献 · Euro Surveill · 2019-01-01

本研究采用BCoDE项目方法估算2017年荷兰水痘(含带状疱疹)的疾病负担,并与其他疫苗可预防疾病在国家免疫规划引入前的负担比较。结果显示水痘负担为1,800 DALYs,其中带状疱疹占91%,低于多数现有免疫规划疾病但高于轮状病毒胃肠炎和B型脑膜炎球菌病。

要点

  • 2017年荷兰水痘疾病负担估计为1,800 DALYs(95%UI:1,800-1,900)。
  • 带状疱疹是水痘疾病负担的主要贡献者,占1,600 DALYs(91%)。
  • 水痘负担高于轮状病毒胃肠炎(1,100 DALYs)和B型脑膜炎球菌病(620 DALYs)。

核心结论

  • 水痘疾病负担低于多数现有国家免疫规划疾病引入前的水平,但高于轮状病毒胃肠炎和B型脑膜炎球菌病这两个潜在候选疫苗疾病。
  • 将水痘疾病负担与其他疫苗可预防疾病负担关联评估,可帮助国家免疫咨询委员会和决策者设定疫苗接种优先级。

研究设计与样本

  • 健康估计报告研究,采用Burden of Communicable Diseases in Europe(BCoDE)项目方法以伤残调整寿命年(DALYs)表达疾病负担。
  • 水痘(含带状疱疹)的发病率、疾病进展模型和参数来自血清流行率、医疗登记和已发表数据,因BCoDE工具包无相关参数。
  • 其他多数疾病的疾病负担使用现有BCoDE参数估算,必要时针对荷兰调整。

主要发现

  • 2017年荷兰水痘疾病负担估计为1,800 DALYs(95%不确定性区间(UI):1,800-1,900)。
  • 带状疱疹主要贡献水痘疾病负担,为1,600 DALYs(91%)。
  • 水痘疾病负担一般低于大多数当前国家免疫规划疾病引入前的负担。
  • 水痘疾病负担高于轮状病毒胃肠炎(1,100 DALYs;95%UI:440-2,200)和B型脑膜炎球菌病(620 DALYs;95%UI:490-770)。

临床怎么用

  • 评估新疫苗引入国家免疫规划时,可参考本方法将目标疾病负担与其他疫苗可预防疾病负担比较,辅助优先级设定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IntroductionEstimating burden of disease (BoD) is an essential first step in the decision-making process on introducing new vaccines into national immunisation programmes (NIPs). For varicella, a common vaccine-preventable disease, BoD in the Netherlands was unknown.AimTo assess national varicella BoD and compare it to BoD of other vaccine-preventable diseases before their introduction in the NIP.MethodsIn this health estimates reporting study, BoD was expressed in disability-adjusted life years (DALYs) using methodology from the Burden of Communicable Diseases in Europe (BCoDE)-project. As no parameters/disease model for varicella (including herpes zoster) were available in the BCoDE toolkit, incidence, disease progression model and parameters were derived from seroprevalence, healthcare registries and published data. For most other diseases, BoD was estimated with existing BCoDE-parameters, adapted to the Netherlands if needed.ResultsIn 2017, the estimated BoD of varicella in the Netherlands was 1,800 (95% uncertainty interval (UI): 1,800-1,900) DALYs. Herpes zoster mainly contributed to this BoD (1,600 DALYs; 91%), which was generally lower than the BoD of most current NIP diseases in the year before their introduction into the NIP. However, BoD for varicella was higher than for rotavirus gastroenteritis (1,100; 95%UI: 440-2,200 DALYs) and meningococcal B disease (620; 95%UI: 490-770 DALYs), two other potential NIP candidates.ConclusionsWhen considering the introduction of a new vaccine in the NIP, BoD is usually estimated in isolation. The current approach assesses BoD in relation to other vaccine-preventable diseases' BoD, which may help national advisory committees on immunisation and policymakers to set vaccination priorities.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. van Lier A, de Gier B, McDonald SA, et al. Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands. Euro Surveill. 2019. PMID: 31064637. doi:10.2807/1560-7917.ES.2019.24.18.1800363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。